Clear Labs Overview

  • Founded
  • 2014

Founded

  • Status
  • Private

  • Employees
  • 101

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $60M

  • Investors
  • 28

Clear Labs General Information

Description

Developer of end-to-end, integrated genomics system designed to simplify complex diagnostics for clinical and applied markets. The company's platfrom provides a fully automated platform that brings together Deoxyribonucleic acid sequencing, robotics, and cloud-based bioinformatics and analytics, it is liberating genomics to all by providing our customers with everything they need to perform next-generation sequencing, leading to increased clarity, and accelerated outcomes, improved accuracy of results and a seamless user experience, enabling labs, hospitals, and companies with genomic insights.

Contact Information

Website
www.clearlabs.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Commercial Services
Biotechnology
Primary Office
  • 1559 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (650) 000-0000

Clear Labs Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clear Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) 26-May-2021 $60M 00000 00000 Completed Generating Revenue
7. Later Stage VC (Series B1) 28-Aug-2020 000.00 0000 000.00 Completed Generating Revenue
6. Early Stage VC (Series B1) 30-Oct-2018 0000 000.00 0000 Completed Generating Revenue
5. Early Stage VC (Series B) 30-Aug-2017 0000 000.00 0000 Completed Generating Revenue
4. Accelerator/Incubator 01-Mar-2016 00.00 Completed Generating Revenue
3. Early Stage VC (Series A2) 05-Oct-2015 00.00 00.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Feb-2014 $1.7M $1.7M 00.00 Completed Generating Revenue
1. Angel (individual) Completed Startup
To view Clear Labs’s complete valuation and funding history, request access »

Clear Labs Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B1 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 6,333,936 $0.000100 8% $1.09 $1.09 1x $1.09 6.76%
Series A 4,928,517 $0.000100 8% $0.35 $0.35 1x $0.35 5.26%
To view Clear Labs’s complete cap table history, request access »

Clear Labs Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of end-to-end, integrated genomics system designed to simplify complex diagnostics for clinical and applied ma
Other Healthcare Technology Systems
San Carlos, CA
101 As of 2023
00000
0000 0000-00-00
00000000000 00000

000000

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitatio
0000000000000
Menlo Park, CA
000 As of 0000
00000
000000000 00000

000000

ehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
0000000000 000000000
San Diego, CA
0000 As of 0000
00.000
000000000 00 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Clear Labs Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacific Biosciences Formerly VC-backed Menlo Park, CA 000 00000 000000000 00000
00000000 Formerly VC-backed San Diego, CA 0000 00.000 000000000 00 00.000
000000 00000000 00 Formerly VC-backed Oxford, United Kingdom 0000 00.000 00000000 00.000
0000000 0000000 00 Corporation Indianapolis, IN 00000
000000 Formerly VC-backed Hilden, Germany 0000 00000 000000&0
You’re viewing 5 of 10 competitors. Get the full list »

Clear Labs Patents

  • 44

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Clear Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4001435-A1 Systems and processes for distinguishing sequences from microorganisms Pending 19-Nov-2020 000000000 00
GB-202116669-D0 Systems and processes for distinguishing sequences from microorganisms Inactive 19-Nov-2020 000000000
GB-2605477-A Systems and processes for distinguishing sequences from microorganisms Inactive 19-Nov-2020 000000000 00
US-20220154270-A1 Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens Pending 19-Nov-2020 000000000
US-11248265-B1 Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens Active 19-Nov-2020 C12Q1/689
To view Clear Labs’s complete patent history, request access »

Clear Labs Executive Team (14)

Name Title Board Seat Contact Info
Sasan Amini Ph.D Co-Founder, Chief Executive Officer & Board Member
Edward Fan Chief Financial Officer
Ramin Khaksar Ph.D Chief Scientific Officer, Chief Operating Officer & Founding Member
Jeff Field Chief Commercial Officer
Henrik Gehrmann Senior Vice President of Engineering
You’re viewing 5 of 14 executive team members. Get the full list »

Clear Labs Board Members (11)

Name Representing Role Since
Gaurav Garg Wing Venture Capital Board Member 000 0000
Greg Yap Menlo Ventures Board Member 000 0000
Michael Robach Clear Labs Board Member 000 0000
Mostafa Ronaghi Ph.D Phi-X Capital Board Member 000 0000
Sasan Amini Ph.D Clear Labs Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Clear Labs Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clear Labs Investors (28)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dafgårds Corporation Minority 000 0000 000000 0
HBM Genomics Venture Capital Minority 000 0000 000000 0
Morgan Stanley Investment Bank Minority 000 0000 000000 0
Prime Partners Venture Capital Minority 000 0000 000000 0
T. Rowe Price Asset Manager Minority 000 0000 000000 0
You’re viewing 5 of 28 investors. Get the full list »

Ready to get started?

Request a free trial